Rationale and Indications for the Use of α‐Keto Analogues
1984; Wiley; Volume: 8; Issue: 1 Linguagem: Inglês
10.1177/014860718400800137
ISSN1941-2444
Autores Tópico(s)Diet and metabolism studies
ResumoJournal of Parenteral and Enteral NutritionVolume 8, Issue 1 p. 37-41 Journal Article Rationale and Indications for the Use of α-Keto Analogues Mackenzie Walser M.D., Mackenzie Walser M.D. Departments of Pharmacology and Experimental Therapeutics and Medicine, Johns Hopkins University School of Medicine, Baltimore, MarylandSearch for more papers by this author Mackenzie Walser M.D., Mackenzie Walser M.D. Departments of Pharmacology and Experimental Therapeutics and Medicine, Johns Hopkins University School of Medicine, Baltimore, MarylandSearch for more papers by this author First published: 01 January 1984 https://doi.org/10.1177/014860718400800137Citations: 10AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1Close JH: The use of amino acid precursors in nitrogen-accumulation diseases. N Engl J Med 290: 663–667, 1974 2Walser M.: Urea cycle disorders and other hereditary hyperammonemic syndromes. IN The Metabolic Basis of Inherited Disease, 5th ed.Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS (eds). McGraw-Hill, New York, 1982, pp 402–438 3Wahren J., Felig P., Hagenfeldt L.: Effect of protein ingestion on splanchnic and leg metabolism in normal man and in patients with diabetes mellitus. J Clin Invest 57: 987–999, 1976 4Elia M., Livesey G.: Branched chain amino acid and oxoacid metabolism in human and rat muscle. IN Metabolism and Clinical Implications of Branched Chain Amino and Ketoacids. Walser M, Williamson JR (eds). Elsevier/ North-Holland, New York, 1981, pp 257–262 5Abumrad NN, Rabin D., Wise KL, et al: The disposal of an intravenously administered amino acid load across the human forearm. Metabolism 31: 463–470, 1982. 6Eriksson LS, Hagenfeldt L., Wahren J.: Intravenous infusion of α-oxoisocaproate : influence on amino acid and nitrogen metabolism in patients with liver cirrhosis. Clin Sci 62: 285–293, 1982 7Shinnick FL, Harper AE: Branched-chain amino acid oxidation by isolated rat tissue preparations. Biochim Biophys Acta 437 : 477–486, 1976 8Chang TW, Goldberg AL: The metabolic fates of amino acids and the formation of glutamine in skeletal muscle. J Biol Chem 253: 3685–3695, 1978 9Hagenfeldt L., Eriksson S., Wahren J.: Influence of leucine on arterial concentrations and regional exchange of amino acids in healthy subjects. Clin Sci 59: 173–181, 1980 10Abumrad NN, Robinson RP, Gooch BR, et al: The effect of leucine infusion on substrate flux across the human forearm. J Surg Res 32: 453–463, 1982 11Walser M., Lund P., Ruderman NB, et al: Synthesis of essential amino acids from their α-keto-analogues by perfused rat liver and muscle. J Clin Invest 52: 2865–2877, 1973 12Pozefsky T., Walser M.: Effect of intraarterial infusion of the ketoanalogue of leucine on amino acid release by forearm muscle. Metabolism 26: 807–815, 1977 13Mitch WE, Walser M., Sapir DG: Nitrogen sparing induced by leucine compared with that induced by its keto analogue, α-ketoisocaproate, in fasting obese man. J Clin Invest 67: 553–562, 1981 14Sapir DG, Stewart PM, Walser M., et al: Effects of α-ketoisocaproate and of leucine on nitrogen metabolism in post-operative patients. Lancet 1: 1010–1014, 1983 15Abumrad NN, Wise KL, Williams PE, et al: Disposal of α-ketoisocaproate : roles of liver, gut, and kidneys. Am J Physiol 243: E123–E131, 1982 16Richards P., Ell S.: Direct evidence for synthesis of valine in man. Lancet 1: 112–114, 1977 17Sapir DG, Walser M.: Nitrogen sparing induced early in starvation by infusion of branched-chain ketoacids. Metabolism 26: 301–308, 1977 18Maddrey WC, Chura C., Coulter AW, et al: Effects of keto-analogues of essential amino acids in portal-systemic encephalopathy. Gastroenterology 71: 190–195, 1976 19Walser M., Sapir DG, Maddrey WC: Use of alpha-keto analogues of essential amino acids. IN Parenteral Nutrition. Fischer J (ed). Little, Brown and Company, Boston, 1976, pp 413–430 20Deleted in proof. 21Schauder P., Schroder K., Herbertz L., et al: Metabolism of exogenous and endogenous valine and α-ketoisocaproic acid in patients with liver cirrhosis and in controls: studies in blood and cerebrospinal fluid. JPEN 6: 343, 1982. 22Barbeau A., Bertrand M., Bouchard R., et al: Effect of a valine load test on plasma α-keto acids in Friedreich ataxia. Can J Neurol Sci 9: 239–242, 1982 23Randle PJ, Lau KS, Parker PJ: Regulation of branched-chain 2-oxoacid dehydrogenase complex. IN Metabolism and Clinical Implications of Branched Chain Amino and Ketoacids. Walser M, Williamson JR (eds). Elsevier/North-Holland, New York, 1981, pp 13–22. 24Lau KS, Fatania HR, Randle PJ: Inactivation of rat liver and kidney branched-chain 2-oxoacid dehydrogenase complex by adenosine triphosphatase. FEBS Lett 126: 66–70, 1981. 25Frick GP, Tai L.-R., Blinder L., et al: L-Leucine activates branched chain α-keto acid dehydrogenase in rat adipose tissue. J Biol Chem 256: 2618–2620, 1981 26Meguid MM, Schwarz H., Matthews DE, et al: IN Amino Acids: Metabolism and Medical Applications. Blackburn GL, Grant JP, Young VR (eds.) Wright-PSG, Littleton, MA, 1983, pp 147–154 27Sherwin RS: Effect of starvation on the turnover and metabolic response to leucine. J Clin Invest 61: 1471–1481, 1978 28Hambraeus L., Bilmazes C., Dippel C., et al: Regulatory role of dietary leucine on plasma branched-chain amino acid levels in young men. J Nutr 106: 230–240, 1976 29Eriksson LS, Felig P., Hagenfeldt L., et al: Leucine uptake by splanchnic and leg tissues in man: independence of insulin levels. JPEN 6: 345, 1982 30Buse MG, Reid SS: Leucine: a possible regulator of protein turnover in muscle. J Clin Invest 56: 1250–1261, 1975 31Fulks RM, Li JB, Goldberg AL: Effects of insulin, glucose, and amino acids on protein turnover in rat diaphragm. J Biol Chem 250: 290–298, 1975. 32Li JB, Jefferson LS: Influence of amino acid availability on protein turnover in perfused skeletal muscle. Biochim Biophys Acta 544: 351–359, 1978 33Lundholm K., Edstrom S., Ekman L., et al: Protein degradation in human skeletal muscle tissue: the effect of insulin, leucine, amino acids and ions. Clin Sci 60: 319–326, 1981 34Buse MG, Atwell R., Mancusi V.: In vitro effect of branched chain amino acids on the ribosomal cycle in muscles of fasted rats. Horm Metab Res 11: 289–292, 1979 35Chua B., Siehl DL, Morgan HE: Effect of leucine and metabolites of branched chain amino acids on protein turnover in heart. J Biol Chem 254: 8358–8362, 1979 36Tischler ME, Desautels M., Goldberg AL: Does leucine, leucyltRNA, or some metabolite of leucine regulate protein synthesis and degradation in skeletal and cardiac muscles? J Biol Chem 257: 1613–1621, 1982 37Tischler ME, Fagan JM: Relationship of the reduction-oxidation state to protein degradation in skeletal and atrial muscle. Arch Biochem Biophys 217: 191–201, 1982 38Seglen PO: Effects of amino acids, ammonia and leupeptin on protein synthesis and degradation in isolated rat hepatocytes. Biochem J 174: 469–474, 1978. 39Kirsch RE, Frith LO'C, Saunders SJ: Stimulation of albumin synthesis by keto analogues of amino acids. Biochim Biophys Acta 442: 437–441, 1976 40Aoki TT, Brennan MF, Fitzpatrick GF, et al.: Leucine meal increases glutamine and total nitrogen release from forearm muscle. J Clin Invest 68: 1522–1528, 1981 41Elia M., Farrell R., Ilic V., et al: The removal of infused leucine after injury, starvation and other conditions in man. Clin Sci 59 : 275–283, 1980 42McNurlan MA, Fern EB, Garlick PJ: Failure of leucine to stimulate protein synthesis in vivo. Biochem J 204: 831–838, 1982 43Walser M., Sapir DG, Mitch WE, et al: Effects of branched chain ketoacids in normal subjects and patients. IN Metabolism and Clinical Implications of Branched Chain Amino and Ketoacids. Walser M, Williamson JR (eds.) Elsevier/ North-Holland, New York, 1981, 291–300 44Krebs HA, Lund P.: Aspects of the regulation of the metabolism of branched-chain amino acids. Adv Enzyme Reg 15: 375–394, 1977 45Palaiologos G., Felig P.: Effects of ketone bodies on amino acid metabolism in isolated rat diaphragm. Biochem J 154: 709–716, 1976 46Morgan HE, Chua BH, Boyd TA, et al: Branched chain amino acids and the regulation of protein turnover in heart and skeletal muscle. IN Metabolism and Clinical Implications of Branched Chain Amino and Ketoacids. Walser M, Williamson JR (eds). Elsevier/ North-Holland, New York, 1981, pp 217–226. 47Landaas S.: Inhibition of branched-chain amino acid degradation by ketone bodies. Scand J Clin Lab Invest 37: 411–418, 1977 48Deleted in proof. 49Schauder P., Matthaei D., Henning HV, et al: Blood levels of branched-chain amino acids and α-ketoacids in uremic patients given keto analogues of essential amino acids. Am J Clin Nutr 33: 1660–1666, 1980 50Deleted in proof. 51Briggs MH, ed. Urea as a Protein Supplement. Pergamon Press, Oxford, 1967 52Mitch WE, Lietman P., Walser M.: Effects of oral neomycin and kanamycin in chronic uremic patients. I. Urea metabolism. Kidney Int 11: 116–122, 1977 53Mitch WE, Walser M.: Effects of oral neomycin and kanamycin in chronic uremic patients. II. Nitrogen balance. Kidney Int 11 : 123–127, 1977 54Heidland A., Kult J., Rockel A., et al: Evaluation of essential amino acids and keto acids in uremic patients on low protein diet. Am J Clin Nutr 31: 1784–1792, 1982 55Walser M.: Ketoacids in the treatment of uremia. Clin Nephrol 3: 180–187, 1975 56Deleted in proof. 57Burns J., Cresswell E., Ell S., et al: Comparison of the effects of keto acid analogues and essential amino acids on nitrogen homeostasis in uremic patients on moderately protein-restricted diets. Am J Clin Nutr 31: 1767–1775, 1978 58Hecking E., Andrzejewski L., Prellwitz W., et al: Double-blind crossover study with oral alpha-ketoacids in patients with chronic renal failure. Am J Clin Nutr 33: 1678–1681, 1980 59Abras E., Walser M.: Nitrogen utilization in uremic patients fed by continuous nasogastric infusion. Kidney Int 22: 392–397, 1982 60Deleted in proof. 61Ando A., Orita Y., Nakata K., et al: The effect of essential amino acid supplementation therapy on prognosis of patients with chronic renal failure estimated on the basis of the Markov process. Med J Osaka U 32: 31–37, 1981 62Walser M.: Nutritional support in renal failure: future directions. Lancet 1: 340–342, 1983 63Deleted in proof. 64Barsotti G., Morelli E., Guiducci A., et al: Reversal of hyperparathyroidism in severe uremics following very low-protein and low-phosphorus diet. Nephron 30: 310–313, 1982 65Fischer JE, Rosen HM, Ebeid AM, et al: The effect of normalization of plasma amino acids on hepatic encephalopathy. Surgery 80: 77–91, 1976 66Marchesini G., Zoli M., Angiolini A., et al: Muscle protein breakdown in liver cirrhosis and the role of altered carbohydrate metabolism. Hepatology 1: 294–299, 1981 67Muting D., Reikowski J.: Improvement of protein tolerance and hyperammonemia in hepatic encephalopathy by oral treatment with ketoanalogues of essential amino acids (ASA). Zschr Gastroenterol 17: 587, 1979 68Herlong HF, Maddrey WC, Walser M.: The use of ornithine salts of branched-chain ketoacids in portal-systemic encephalopathy. Ann Intern Med 93: 545–550, 1980 69Walker S., Gotz R., Czygan P., et al: Oral keto analogs of branched-chain amino acids in hyperammonemia in patients with cirrhosis of the liver. A double-blind crossover study. Digestion 24: 105–111, 1982 70Borghi L., Novarini A., Ghinelli F., et al: Preliminary report on nutritional effects of α-ketoacids in chronic hepatic and renal failure. JPEN 6: 328, 1982 71Mendell JR, Griggs RC, Moxley R., et al: A double-blind controlled trial of leucine in Duchenne muscular dystrophy. Ann Neurol 12: 78, 1982 72Stewart PM, Walser M., Drachman DB: Branched-chain ketoacids reduce muscle protein degradation in Duchenne muscular dystrophy. Muscle Nerve 5: 197–201, 1982 Citing Literature Volume8, Issue1January 1984Pages 37-41 ReferencesRelatedInformation
Referência(s)